Abivax SA (ABVX)
NASDAQ: ABVX · IEX Real-Time Price · USD
12.40
-0.45 (-3.50%)
At close: Jul 19, 2024, 4:30 PM
12.34
-0.06 (-0.48%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Abivax Market Cap
Abivax has a market cap or net worth of $780.18 million as of July 22, 2024.
Market Cap
780.18M
Enterprise Value
576.85M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.40
Market Cap Chart
Since October 20, 2023, Abivax's market cap has increased from $521.80M to $780.18M, an increase of 49.52%. That is a compound annual growth rate of 71.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 780.30M | 16.00% |
| Dec 29, 2023 | 672.70M | 28.92% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atrion | 804.30M |
| Olema Pharmaceuticals | 800.41M |
| Immunome | 798.19M |
| Aurinia Pharmaceuticals | 795.19M |
| Simulations Plus | 791.10M |
| Dianthus Therapeutics | 779.52M |
| OrthoPediatrics | 776.11M |
| Erasca | 766.54M |